WHO/HIV/SIP
Accessed: 28.11.2019
Website last accessed on 08.09.2022
Dengue testing guidance according to days of symptom onset.
Lack of Access to Reproductive Healthcare in Sudan’s Rebel-Held Southern Kordofan
Website last accessed on 14.04.2023
One of the ongoing challenges with neglected tropical diseases (NTDs) is that the discovery of medicines to treat them has been very slow. Current global programmes for NTDs largely depend on donated medicines, primarily to treat the world’s poorest people ... most of whom live in remote rural or in deprived urban settings.
WHO recently spoke to Mr Robert J. Gyurik, who discovered albendazole in 1972. He took us through the journey that led him to develop the compound.
more
Websites last accessed on 04.04.2023
Chagas disease, also known as the “kissing disease,” is considered one of the Neglected Tropical Diseases (NTDs), which are diseases that have been forgotten by developed countries because they usually plague lower-income countries.
Novel Coronavirus (COVID-19)
Accessed: 08.04.2020
Website last accessed on 10.09.2022
Plataforma del Ministerio de Salud, donde se pueden descargar guías clínicas sobre diversas enfermedades
Novel Coronavirus (COVID-19)
Accessed: 08.04.2020
Website last accessed on 31.03.2023
Novel Coronavirus (COVID-19)
Accessed: 08.04.2020
Russian Federation
Accessed: 24.09.2019
Novel Coronavirus (COVID-19)
Accessed: 08.04.2020
Interim guidance
Accessed: 02.04.2020
الص العالي لض ف-19
الاج ع العو الة فوس رونا ال 2019
إرشادات مئة
27 ف ا.../ شا 2020
more
Web page access : 28.04.2017
Guidance for the prevention of volcanic ash rain: before, during and after the ash rain
Novel Coronavirus (COVID-19)
Accessed: 08.04.2020
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Handout presentations in PDF for illustrating lectures
Accessed May 2014
Le guide
Ratgeber Parkinson – Französisch
Accessed: 11.03.2019
These organisations have joined forces to accelerate access to COVID-19 vaccines, therapeutics and diagnostics by leveraging multilateral finance and trade solutions, particularly for low- and middle-income countries.
The aim is to vaccinate at least 40 percent of people in every country by the end... of 2021, and at least 60 percent by mid-2022. The effort will track, coordinate, and advance delivery of COVID-19 vaccines, therapeutics and diagnostics, working with governments and partners at the global and local levels to address finance and trade barriers to ensure that vulnerable populations have access to these life-saving tools. It supports the goals of the ACT-Accelerator and complementary initiatives.
more